CODIOVAN FORTE 320 mg/25 mg Comp. recub. con película (IP) CO-DIOVAN FORTE 320 mg/25 mg Comp. recub. con película (IP) COPALIA 10 mg/160 mg Comp. recub. con película COPALIA 5 mg/160 mg Comp. recub. con película CO-VALS 160/12,5 mg Comp. recub. con película EXFORGEHCT aa 10/320/25 mg Comp. recub. con película,efectos secundarios, efectos adversos, precio (Amlodipino,Hidroclorotiazida,Valsartán) CO-DIOVAN FORTE 320 mg/25 mg Comp. recub. con película; COLIRCUSI PILOCARPINA 20 mg/ml Colirio en sol. COSENTYX 150 mg Sol. iny. en jeringa prec; CoDiovan 320/12.5 tablets are oval shaped, and pink in colour. Co-Diovan 320/25 mg tablets. AUST R 135812 . Internal document code: (cod271022c) based on PI (cod271022i)

CoDiovan 160/25 mg Tablets: Oval, non-divisible, film-coated tablets measuring approximately 14.2 mm by 5.7 mm and 4.5 mm in thickness, (Calculations assume an oral dose of 320 mg/day valsartan in combination with 25

CoDiovan 160 mg/12.5 mg and Co-Diovan forte Filmtabletten 160 mg/25 mg were approved in Germany on 16 December 2002 and 9 February 2004, respectively. On 13 April 2007 the 320 mg/12.5 mg and 320 mg/25 mg strengths were registered. Co-Diovan has been approved via MRP (SE/H/0565) in all CMSs involved in this procedure.
Characteristics The reference product used in the bio-equivalence study is Co Diovan Forte tabletsmarketed by Novartis Pharma GmbHinGermany II. QUALITY ASPECTS II.1 Introduction Valsartan/Hydrochlorothiazide CT, film-coated tablets containing 320 of valsartan and 12.5 mg of hydrochlorothiazide or 320 of valsartan and 25 mg of wx9B. 487 137 460 188 337 165 245 12 488

co diovan forte 320 mg 25 mg